Trial Profile
Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs TG 1042 (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 10 Oct 2015 New trial record